Solventum Corporation (SOLV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Key Insights
Critical company metrics and information
Share Price
$69.63Market Cap
$12.03 BillionTotal Outstanding Shares
172.76 Million SharesTotal Employees
22,000Dividend
No dividendIPO Date
March 26, 2024SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.3m.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-93.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-202.00 Million |
Net Cash Flow | $-126.00 Million |
Net Cash Flow, Continuing | $-126.00 Million |
Net Cash Flow From Operating Activities, Continuing | $169.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-93.00 Million |
Net Cash Flow From Operating Activities | $169.00 Million |
Net Cash Flow From Financing Activities | $-202.00 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Basic Average Shares | $173.40 Million |
Gross Profit | $1.17 Billion |
Income/Loss From Continuing Operations After Tax | $122.00 Million |
Diluted Earnings Per Share | $0.70 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Diluted Average Shares | $173.90 Million |
Income Tax Expense/Benefit | $45.00 Million |
Cost Of Revenue | $917.00 Million |
Net Income/Loss | $122.00 Million |
Net Income/Loss Attributable To Parent | $122.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Revenues | $2.08 Billion |
Income Tax Expense/Benefit, Deferred | $-37.00 Million |
Net Income/Loss Available To Common Stockholders, Basic | $122.00 Million |
Research and Development | $189.00 Million |
Benefits Costs and Expenses | $1.92 Billion |
Operating Expenses | $890.00 Million |
Income/Loss From Continuing Operations Before Tax | $167.00 Million |
Basic Earnings Per Share | $0.70 |
Costs And Expenses | $1.81 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Selling, General, and Administrative Expenses | $701.00 Million |
Operating Income/Loss | $275.00 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Current Liabilities | $2.90 Billion |
Fixed Assets | $1.60 Billion |
Other Current Assets | $2.40 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Inventory | $953.00 Million |
Liabilities | $11.55 Billion |
Other Non-current Liabilities | $540.00 Million |
Current Assets | $3.35 Billion |
Intangible Assets | $2.65 Billion |
Noncurrent Liabilities | $8.65 Billion |
Wages | $251.00 Million |
Long-term Debt | $8.11 Billion |
Liabilities And Equity | $14.74 Billion |
Assets | $14.74 Billion |
Other Current Liabilities | $2.09 Billion |
Equity Attributable To Parent | $3.19 Billion |
Other Non-current Assets | $7.14 Billion |
Accounts Payable | $560.00 Million |
Noncurrent Assets | $11.39 Billion |
Equity | $3.19 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.